• Cesar, J.M., Vecino, A., Perez-Vaquero, M. & Navarro, J.L. (1993) Phospholipid determination in platelets, plasma and red cells of patients with chronic myeloproliferative disorders. European Journal Haematology, 50, 234236.
  • Föller, M., Kasinathan, R.S., Koka, S., Huber, S.M., Schuler, B., Vogel, J., Gasmann, M. & Lang, F. (2007) Enhanced susceptibility to suicidal death of erythrocytes from transgenic mice overexpressing erythropoietin. American Journal of Physiology Regulatory Integrative and Comparative Physiology, 293, R1127R1134.
  • Haynes, Jr, J., Obiako, B., Hester, R.B., Baliga, B.S. & Stevens, T. (2008) Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium. American Journal of Physiology Heart and Circulatory Physiology, 294, H379H385.
  • Hebbel, R.P. (1991) Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood, 77, 214.
  • Kemmpe, D.S., Lang, P.A., Duraton, C., Akel, A., Lanf, K.S., Huber, S.M., Wieder, T. & Lang, F. (2006) Enhanced programmed cell death of iron-deficient erythrocytes. FASEB Journal, 20, 368370.
  • Pavic, M., Francina, A., Durand, D.V. & Rousset, H. (2003) Polycythaemia and iron deficiency. The Lancet, 362, 1624.
  • Qadri, S.M., Föller, M. & Lang, F. (2009) Inhibition of suicidal erythrocyte death by resveratrol. Life Science, 85, 3338.
  • Vardiman, J.W., Thiele, J., Arber, D.A., Brunning, R.D., Borowitz, M.J., Porwit, A., Harris, N.L., Le Beau, M.M., Lindberg, E.H., Tefferi, A. & Bloomfield, C.D. (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood, 114, 937951.
  • Wood, B.L., Gibson, D.F. & Tait, J.F. (1996) Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow cytometric measurement and clinical association. Blood, 88, 18731880.